Filed: 8/13/2025ACC: 0001104659-25-077546
📋 What this filing means
CATALYS PACIFIC, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $131.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$131.66M
Total AUM (reported)
10.07M
Total Shares
Allocation by class
COM$131.66M100.0%
Portfolio Concentration
Top 3$131.66M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.07M
Sole
Full voting authority
10.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Mineralys Therapeutics, Inc.
SOLEShares8.90M
TypeSH
Market value$120.47M
91.50%
Sole
8.90M
Shared
0.00
None
0.00
Phathom Pharmaceuticals, Inc.
SOLEShares1.17M
TypeSH
Market value$11.19M
8.50%
Sole
1.17M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc.SOLE | COM | 8.90M | SH | $120.47M 91.50% | 8.90M | 0.00 | 0.00 |
Phathom Pharmaceuticals, Inc.SOLE | COM | 1.17M | SH | $11.19M 8.50% | 1.17M | 0.00 | 0.00 |